Source: https://sharpbrains.com/blog/2018/06/13/fda-clears-mindmaze-go-neurorehabilitation-platform-easing-access-to-continued-outpatient-therapy/
___
MindMaze Consolidates First-ever FDA Approval for Inpatient and Outpatient Neurorehabilitation Therapy (press release):
“MindMaze, a leader in braintech, has today announced that it has obtained FDA clearance to launch its portable neurorehabilitation product, MindMotion
GO, in the United States. Together with MindMotion PRO (which received FDA clearance in 2017), MindMotion GO is the next offering in the company’s continuum of care, providing gamified neurorehabilitation therapy.
“Now that both MindMotion products have FDA clearance, MindMaze delivers a full spect…
Source: https://sharpbrains.com/blog/2018/06/13/fda-clears-mindmaze-go-neurorehabilitation-platform-easing-access-to-continued-outpatient-therapy/
___
MindMaze Consolidates First-ever FDA Approval for Inpatient and Outpatient Neurorehabilitation Therapy (press release):
“MindMaze, a leader in braintech, has today announced that it has obtained FDA clearance to launch its portable neurorehabilitation product, MindMotion GO, in the United States. Together with MindMotion PRO (which received FDA clearance in 2017), MindMotion GO is the next offering in the company’s continuum of care, providing gamified neurorehabilitation therapy.
“Now that both MindMotion products have FDA clearance, MindMaze delivers a full spect…
What Do You Think?
comments